课题基金 / 基金详情

NITRO: A randomised phase 3 trial of adding nitroglycerin to first line chemotherapy for advanced non-small cell lung cancer

NITRO: A randomised phase 3 trial of adding nitroglycerin to first line chemotherapy for advanced non-small cell lung cancer
NITRO:一项在晚期非小细胞肺癌一线化疗中添加硝酸甘油的随机 3 期试验
批准号:
nhmrc : 1065856
负责人:
A/Pr Andrew Davidson
金额:
$33.67万
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2014
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2014-01-01 至 2016-12-31

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Preliminary studies suggest that nitroglycerin paste can substantially improve the results of chemotherapy for advanced lung cancer. NITRO is a definitive, large-scale, randomised trial that is needed to reliably determine if these promising results are true, and worthy of widespread application in routine clinical practice.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金